4. Lin YH, Tseng YH, Chen YC, Lin MH, Chou LF, Chen TJ, et al. The rural - urban divide in ambulatory care of gastrointestinal diseases in Taiwan. BMC international health and human rights 2013;13:15 doi 10.1186/1472-698X-13-15.
6. Tseng YH, Hung HY, Sung YC, Tseng YC, Lee YC, Whang-Peng J, et al. Efficacy of chemotherapy in epidermal growth factor receptor (EGFR) mutated metastatic pulmonary adenocarcinoma patients who had acquired resistance to first-line EGFR tyrosine kinase inhibitor (TKI). Journal of chemotherapy 2016;28(1):50-8 doi 10.1179/1973947815Y.0000000027.
7. Tseng YH, Tseng YC, Lin YH, Lee YC, Perng RP, Whang-Peng J, et al. Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Treatment and Salvage Chemotherapy in EGFR-Mutated Elderly Pulmonary Adenocarcinoma Patients. The oncologist 2015;20(7):758-66 doi 10.1634/theoncologist.2014-0352.
8. Lin YH, Tseng YH, Chang HT, Lin MH, Tseng YC, Chen TJ, et al. Interdisciplinary, interinstitutional and international collaboration of family medicine researchers in Taiwan. PeerJ 2015;3:e1321 doi 10.7717/peerj.1321.
9. Tseng YH, Lin YH, Tseng YC, Lee YC, Wu YC, Hsu WH, et al. Adjuvant Therapy for Thymic Carcinoma--A Decade of Experience in a Taiwan National Teaching Hospital. PloS one 2016;11(1):e0146609 doi 10.1371/journal.pone.0146609.
10. Hung HY, Tseng YH, Liao CM, Chen SY, Wu TP, Lee YC, et al. The Efficacy of Traditional Chinese Herbal Medicine in the Treatment of EGFR Mutated Stage IV Pulmonary Adenocarcinoma Patients Who Received First-Line EGFR-TKI Treatment. Integrative cancer therapies 2017;16(1):126-31 doi 10.1177/1534735416645181.
11. Tseng YH, Ko HK, Tseng YC, Lin YH, Kou YR. Atrial Fibrillation on Intensive Care Unit Admission Independently Increases the Risk of Weaning Failure in Nonheart Failure Mechanically Ventilated Patients in a Medical Intensive Care Unit: A Retrospective Case-Control Study. Medicine 2016;95(20):e3744 doi 10.1097/MD.0000000000003744.
12. Tseng YC, Tseng YH, Kao HL, Hsieh CC, Chou TY, Goan YG, et al. Long term oncological outcome of thymoma and thymic carcinoma - an analysis of 235 cases from a single institution. PloS one 2017;12(6):e0179527 doi 10.1371/journal.pone.0179527.
13. Tseng YH, Ho HL, Lai CR, Luo YH, Tseng YC, Whang-Peng J, et al. PD-L1 Expression of Tumor Cells, Macrophages, and Immune Cells in Non-Small Cell Lung Cancer Patients with Malignant Pleural Effusion. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2018;13(3):447-53 doi 10.1016/j.jtho.2017.10.034.
15. Hung HY, Tseng YH, Chao HS, Chiu CH, Hsu WH, Hsu HS, Multidisciplinary team discussion results in survival benefit for patients with stage III non-small-cell lung cancer
16. Lin YH, Chen YC, Tseng YC, Tsai ST, Tseng YH. Physical activity and successful aging among middle-aged and older adults: a systematic review and meta-analysis of cohort studies. Aging 2020;12(9):7704-16 doi 10.18632/aging.103057.